The Steep Toll of Endocrine Therapy on Breast Cancer Patients

Host: Matt Birnholz, MD

Guest: Dawn L. Hershman, MD, MS

Much of the focus on endocrine therapy tends to be around future directions and what new treatments are going to accelerate care for breast cancer patients. But oncologists need to take stock of how physically and financially costly it can be, as Dr. Dawn Hershman explains to Dr. Matt Birnholz at the 2019 San Antonio Breast Cancer Symposium.